Claus Normann, MD
University of Freiburg, Dep. of Psychiatry · Department of Psychiatry, University of Freiburg · Dept. of Psychiatry, University of Freiburg
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Claus Normann, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:20 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT00837564 · Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic DepressionUniversity Hospital Freiburg · unknown · Chronic Depression · principal investigator
- Ph3NCT00276978 · Aripiprazole Augmentation Therapy in Treatment-resistant DepressionUniversity Hospital Freiburg · withdrawn · Therapy-resistant Depression · principal investigator
- Ph3NCT00273624 · Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled TrialUniversity Hospital Freiburg · withdrawn · Therapy-resistant Depression · principal investigator
- N/ANCT00263133 · Modulation of Visually Evoked Potentials by an AntidepressantUniversity Hospital Freiburg · completed · Depression · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.